Abstract
Aim: We examined prevalence and factors associated with receiving perceived helpful alcohol use disorder (AUD) treatment, and persistence in help-seeking after earlier unhelpful treatment. Methods: Data came from 27 community epidemiologic surveys of adults in 24 countries using the World Health Organization World Mental Health surveys (n = 93,843). Participants with a lifetime history of treated AUD were asked if they ever received helpful AUD treatment, and how many professionals they had talked to up to and including the first time they received helpful treatment (or how many ever, if they had not received helpful treatment). Results: 11.8% of respondents with lifetime AUD reported ever obtaining treatment (n = 9378); of these, 44% reported that treatment was helpful. The probability of obtaining helpful treatment from the first professional seen was 21.8%; the conditional probability of subsequent professionals being helpful after earlier unhelpful treatment tended to decrease as more professionals were seen. The cumulative probability of receiving helpful treatment at least once increased from 21.8% after the first professional to 79.7% after the seventh professional seen, following earlier unhelpful treatment. However, the cumulative probability of persisting with up to seven professionals in the face of prior treatments being unhelpful was only 13.2%. Conclusion: Fewer than half of people with AUDs who sought treatment found treatment helpful; the most important factor was persistence in seeking further treatment if a previous professional had not helped. Future research should examine how to increase the likelihood that AUD treatment is found to be helpful on any given contact.
Original language | English |
---|---|
Article number | 109158 |
Journal | Drug and Alcohol Dependence |
Volume | 229 |
DOIs | |
State | Published - 1 Dec 2021 |
Funding
Funders | Funder number |
---|---|
Alcohol Advisory Council | |
Argentinian Ministry of Health | |
CES University | |
Center for Excellence on Research in Mental Health | |
Drug and Alcohol Program | |
Eli Lilly Romania SRL | |
European Economic Area Financial Mechanism | |
Federal Ministry of Health, Abuja, Nigeria | |
Fundaci?n para la Formaci?n e Investigaci?n Sanitarias | |
Gulbenkian Foundation | |
INPRFMDIES | 4280 |
Institute of Psychiatry and Neurology | |
Israel National Health Survey | |
Israel National Institute for Health Policy and Health Services Research | |
Lebanese Evaluation of the Burden of Ailments and Needs Of the Nation | |
Medical University in Wroclaw | |
Mexican National Comorbidity Survey | |
Ministerio de Ciencia y Tecnolog?a | 158-CE |
Ministerio de Salud de la Naci?n | |
Ministry of Social Protection | |
NOVA University of Lisbon | |
National Center for Public Health Protection | |
National Institute for Research & Development in Health | |
National Institute of Public Health-National Institute of Hygiene in Warsaw | |
National Institute of Statistics | |
New Zealand Mental Health Survey | |
Nigerian Survey of Mental Health and Wellbeing | |
Norwegian Financial Mechanism | |
Ortho-McNeil Pharmaceutical Inc. | |
Portuguese Catholic University | |
S?o Paulo Megacity Mental Health Survey | |
Servicio Murciano de Salud and Consejería de Sanidad y Política Social | |
South African Department of Health | |
São Paulo Megacity Mental Health Survey | |
WMH | |
World Health Organization World Mental Health | |
National Institutes of Health | |
National Institute of Mental Health | R01 MH070884, U01-MH60220, R01-MH059575 |
National Institute on Drug Abuse | R01DA1104470 |
Substance Abuse and Mental Health Services Administration | |
Fogarty International Center | R03TW006481 |
Robert Wood Johnson Foundation | 044708 |
John D. and Catherine T. MacArthur Foundation | |
John W. Alden Trust | |
Eli Lilly and Company | |
GlaxoSmithKline | |
World Health Organization | R03 TW006481 |
U.S. Public Health Service | R01 DA016558, R13-MH066849, R01-MH069864 |
University of Michigan | |
Pfizer Foundation | |
Pan American Health Organization | |
Ministerio de Sanidad, Consumo y Bienestar Social | |
European Commission | SANCO 2004123, EAHC 20081308, QLG5–1999-01042, 1999-01042 |
National Health and Medical Research Council | 1135991 |
Department of Health and Ageing, Australian Government | |
Ministry of Health, New Zealand | |
Health Research Council of New Zealand | |
Public Health Agency | |
University of New South Wales | |
Fundação de Amparo à Pesquisa do Estado de São Paulo | 03/00204–3, 03/00204? |
Fundação para a Ciência e a Tecnologia | |
Generalitat de Catalunya | 2014 SGR 748, RETICS RD06/0011 REM-TAP, 2017 SGR 452, CB06/02/0046 |
Consejo Nacional de Ciencia y Tecnología | CONACyT-G30544- H |
National Insurance Institute of Israel | H25-SEISHIN-IPPAN-006, H16-KOKORO-013, H14-TOKUBETSU-026, H13-SHOGAI-023 |
Ministerio de Salud de la Nación | 2002–17270/13 − 5 |
Ministry of Health, Labour and Welfare | |
Conselho Nacional de Desenvolvimento Científico e Tecnológico | 307933/2019–9 |
Department of Health and Aged Care, Australian Government | |
Ministry of Public Health | |
Instituto de Salud Carlos III | FIS 00/0028 |
Ministerio de Ciencia y Tecnología | SAF 2000–158-CE |
EEA Grants | |
National Drug and Alcohol Research Centre | |
NSW Ministry of Health | |
Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz | |
Fundación para la Formación e Investigación Sanitarias de la Región de Murcia | |
Regione Piemonte | |
Departament de Salut, Generalitat de Catalunya | |
EEA Grants/Norway Grants | |
Fundação Champalimaud | |
Ministerio de Salud | PL 0256 |
Ministerstwo Zdrowia |
Keywords
- Alcohol use disorder
- Epidemiology
- Treatment